Healthy pregnant women No hematological diasease
Conditions
Interventions
Ferrous fumarate 2oo mg oral daily,Ferrous fumarate 2oo mg oral daily plus
Ascobic acid 500 mg oral daily
Placebo Comparator Drug,Experimental Drug
Sponsors
Phramongkutklao College of Medicine
Phramongkulklao hospital
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Pregnant women, aged ≥18 years, attending antenatal clinic of Phramongkutklao hospital Singleton pregnancy Hematocrit ≥33 mg% Gestational age 14-18 week
Exclusion criteria
Exclusion criteria: Drug allergy : Ascorbic acid, Ferrous fumarate Chronic disease ex. chronic infection, autoimmune disease (especially RA), kidney disease, or cancerDrug allergy : Ascorbic acid, Ferrous fumarate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maternal Hematologic status in pregnancy Pre intervention hematocrit value and post intervention hematocrit value at 12 week after interventi Pre intervention hematocrit value and post intervention hematocrit value | — |
Secondary
| Measure | Time frame |
|---|---|
| Demographics data affect to iron deficiency anemia Demographics data at pre intervention date Demographics data of volunteer , example age, occupation, education, underlying disease | — |
Countries
Thailand
Contacts
Public ContactTaranun Klinsrisuk
Phramonkutklao hospital
Outcome results
None listed